Acrolein effects in pulmonary cells: Relevance to chronic obstructive pulmonary disease

Annals of the New York Academy of Sciences

Volumn 1259, Issue 1, 2012, Pages 39-46

  Moretto, Nadia ^a   Volpi, Giorgia ^a   Pastore, Fiorella ^a   Facchinetti, Fabrizio ^a  

^a CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Acrolein; Glutathione; Inflammation; Neutrophils; Oxidative stress; Proteases; Stress kinases

Indexed keywords

ACETYLCYSTEINE; ACROLEIN; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; RESVERATROL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DRUG MEGADOSE; ELECTROPHILICITY; ENZYME ACTIVATION; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; LUNG ALVEOLUS CELL; MUCUS SECRETION; NEUTROPHIL; OXIDATIVE STRESS; PROTEIN MODIFICATION; RESPIRATORY EPITHELIUM; RNA TRANSLATION; SIGNAL TRANSDUCTION;

NICOTIANA TABACUM;

EID: 84863506167     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06531.x     Document Type: Article

References (92)

1. Celli, B.R. & W. MacNee 2004. ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23: 932-946.
2. Rabe, K.F. et al 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Global Initiative for Chronic Obstructive Lung Disease. Am. J. Respir. Crit. Care Med. 176: 532-555.
3. Barnes, P.J. 2007. Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 4: e112.
4. Stedman, R.L. 1968. The chemical composition of tobacco and tobacco smoke. Chem. Rev. 68: 153-207.
5. Bein, K. & G.D. Leikauf 2011. Acrolein-a pulmonary hazard. Mol. Nutr. Food Res. 55: 1342-1360.
6. Esterbauer, H., R.J. Schaur & H. Zollner 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11: 81-128
7. Stevens, J.F. & C.S. Maier 2008. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52: 7-25.
8. Corradi, M. et al 2004. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur. Respir. J. 24: 1011-1017.
9. Witz, G. 1989. Biological interactions of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 7: 333-349.
10. Valko, M. et al 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39: 44-84.
11. Meister, A. & M.E. Anderson 1983. Glutathione. Annu. Rev. Biochem. 52: 711-760.
12. Spiess, P.C. et al 2011. Proteomic profiling of acrolein adducts in human lung epithelial cells. J. Proteomics. 74: 2380-2394.
13. Myers, C. R. & J.M. Myers 2009. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology 257: 95-104.
14. Thompson, C.A. & P.C. Burcham 2008. Genome-wide transcriptional responses to acrolein. Chem. Res. Toxicol. 21: 2245-2256.
15. Liu, X.Y., M.X. Zhu & J.P. Xie 2010. Mutagenicity of acrolein and acrolein-induced DNA adducts. Toxicol. Mech. Methods 20: 36-44.
16. Dalle-Donne, I. et al. 2007. Actin Cys374 as a nucleophilic target of alpha, beta-unsaturated aldehydes. Free Radic. Biol. Med. 42: 583-598.
17. Burcham, P.C., A. Raso & C.A. Thompson 2010. Intermediate filament carbonylation during acute acrolein toxicity in A549 lung cells: functional consequences, chaperone redistribution, and protection by bisulfite. Antioxid. Redox Signal. 12: 337-347.
18. Horton, N.D. et al 1999. Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J. Biol. Chem. 274: 9200-9206.
19. Lambert, C. et al 2007. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-kappaB1 DNA binding domain. J. Biol. Chem., 282: 19666-19675.
20. Tirumalai, R. et al 2002. Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial (A549) cells. Toxicol. Lett. 132: 27-36.
21. Kehrer, J.P. & S.S. Biswal 2000. The molecular effects of acrolein. Toxicol. Sci. 57: 6-15.
22. Li, L. et al 1997. Acrolein induced cell death in human alveolar macrophages. Toxicol. Appl. Pharmacol. 145: 331-339.
23. Tanel, A. & D.A. Averill-Bates 2005. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim. Biophys. Acta. 1743: 255-267.
24. Hoshino, Y. et al 2001. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell derived cell line. Am. J. Physiol. Lung. Cell Mol. Physiol. 281: L509-L516.
25. Nardini, M. et al 2002. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 170: 173-185.
26. Roy, J. et al 2009. Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem. Biol. Interact. 181: 154-167.
27. Roy, J. et al 2010. Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53. Can. J. Physiol. Pharmacol. 88: 353-368.
28. Stämpfli, M.R. & G.P Anderson 2009. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat. Rev. Immunol. 9: 377-384.
29. Schäfer, H. & S. Ewig 2000. Acute exacerbations in chronic obstructive pulmonary disease (COPD)-microbial patterns and risk factors. Monaldi. Arch. Chest Dis. 55: 415-419.
30. Jakab, G.J. 1977. Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung. Am. Rev. Respir. Dis. 115: 33-38.
31. Li, L. & A. Holian 1998. Acrolein: a respiratory toxin that suppresses pulmonary host defense. Rev. Environ. Health 13: 99-108.
32. Low, E.S., R.B. Low & G.M. Green 1977. Correlated effects of cigarette smoke components on alveolar macrophage adenosine triphosphatase activity and phagocytosis. Am. Rev. Respir. Dis. 115: 963-970.
33. Lee, J.S. et al 2008. Acrolein with an alpha, beta-unsaturated carbonyl group inhibits LPS-induced homodimerization of toll-like receptor 4. Mol. Cells 25: 253-257.
34. Hristova, M. et al 2011. The tobacco smoke component acrolein suppresses innate macrophage responses by direct alkylation of c-Jun-N-terminal kinase. Am. J. Respir. Cell Mol. Biol. Jul 21.
35. Facchinetti, F. et al 2007. Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am. J. Respir. Cell. Mol. Biol. 37: 617-623.
36. Moretto, N. et al 2009. alpha, beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am. J. Physiol. Lung. Cell Mol. Physiol. 296: L839-L848.
37. Volpi, G. et al 2011. Cigarette smoke and α, β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts. Br. J. Pharmacol. 163: 649-661
38. Sarkar, P. & B.E Hayes 2007. Induction of COX-2 by acrolein in rat lung epithelial cells. Mol. Cell Biochem. 301: 191-199.
39. Li, L., R.F. Jr Hamilton & A. Holian 1999. Effect of acrolein on human alveolar macrophage NF-kappaB activity. Am. J. Physiol. 277(3 Pt 1): L550-L557.
40. Ji, C., K.R. Kozak & L.J. Marnett 2001. IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 276: 18223-18228.
41. Valacchi, G. et al 2005. Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid. Redox. Signal. 7: 25-31.
42. Kent, L. et al 2008. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine. 42: 205-216.
43. Kasahara, D.I. et al 2008. Acrolein inhalation suppresses lipopolysaccharide-induced inflammatory cytokine production but does not affect acute airways neutrophilia. J Immunol. 181: 736-745
44. Finkelstein, E.I., M. Cardini & A. van der Vliet 2001. Inhibition of neutrophil apoptosis by acrolein: a mechanism of tobacco-related lung disease? Am. J. Physiol. Lung. Cell Mol. Physiol. 281: L732-L739.
45. Finkelstein, E.I. et al 2005. Regulation of constitutive neutrophil apoptosis by the alpha, beta-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am. J. Physiol. Lung. Cell Mol. Physiol. 289: L1019-L101928.
46. Andrè, E. et al 2008. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J. Clin. Invest. 118: 2574-2582.
47. Leikauf, G.D. et al 2002. Mucin apoprotein expression in COPD. Chest 121(5 Suppl): 166S-182S.
48. Johnson, D.C. 2011. Airway mucus function and dysfunction. N. Engl. J. Med. 364: 978.
49. Fan, H. & L.A. Bobek 2010. Regulation of human MUC7 mucin gene expression by cigarette smoke extract or cigarette smoke and pseudomonas aeruginosa lipopolysaccharide in human airway epithelial cells and in MUC7 transgenic mice. Open Respir. Med. J. 14: 63-70.
50. Thai, P. et al 2008. Regulation of airway mucin gene expression. Annu. Rev. Physiol. 70: 405-429.
51. Baginski, T.K. et al 2006. Cigarette smoke synergistically enhances respiratory mucin induction by proinflammatory stimuli. Am. J. Respir. Cell Mol. Biol. 35: 165-174.
52. Costa, D.L. et al 1986. Altered lung function and structure in the rat after subchronic exposure to acrolein. Am. Rev. Respir. Dis. 133: 286-291.
53. Borchers, M.T., S.E. Wert & G.D. Leikauf 1998. Acrolein-induced MUC5ac expression in rat airways. Am. J. Physiol. 274(4 Pt 1): L573-L581.
54. Borchers, M.T. et al 1999. Monocyte inflammation augments acrolein-induced Muc5ac expression in mouse lung. Am. J. Physiol. 277(3 Pt 1): L489-L497.
55. Dorman, D.C. et al 2008. Respiratory tract responses in male rats following subchronic acrolein inhalation. Inhal. Toxicol. 20: 205-216.
56. Borchers, MT., M.P Carty & G.D. Leikauf 1999. Regulation of human airway mucins by acrolein and inflammatory mediators. Am. J. Physiol. 276(4 Pt 1): L549-L555.
57. Deshmukh, H.S. et al 2005. Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. Am. J. Respir. Crit. Care Med. 171: 305-314.
58. Deshmukh, H.S. et al 2009. Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am. J. Respir. Crit. Care Med. 180: 834-845.
59. Liu, D.S. et al 2009. p38 MAPK and MMP-9 cooperatively regulate mucus overproduction in mice exposed to acrolein fog. Int. Immunopharmacol. 9: 1228-1235.
60. Deshmukh, H.S. et al 2008. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am. J. Respir. Cell Mol. Biol. 38: 446-454.
61. Ren, S. et al 2011. Doxycycline attenuates acrolein-induced mucin production, in part by inhibiting MMP-9. Eur. J. Pharmacol. 650: 418-423.
62. Chen, Y.J. et al 2010. Simvastatin attenuates acrolein-induced mucin production in rats: involvement of the Ras/extracellular signal-regulated kinase pathway. Int. Immunopharmacol. 10: 685-693.
63. Shapiro, S.D. & E.P. Ingenito 2005. The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. Am. J. Respir. Cell Mol. Biol. 32: 367-372.
64. Demkow, U. & F.J. van Overveld 2010. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment. Eur. J. Med. Res. 15(Suppl 2): 27-35.
65. Vernooy, J.H. et al 2004. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 126: 1802-1810.
66. Molet, S. et al 2005. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm. Res. 54: 31-36.
67. Oikonomidi, S. et al 2009. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr. Med. Chem. 16: 1214-1228.
68. Lemaître, V., A.J. Dabo & J. D'Armiento 2011. Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol. Sci. 123: 542-549.
69. O'Toole, T.E. et al 2009. Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages. Toxicol. Appl. Pharmacol. 236: 194-201.
70. Kim, C.E. et al 2010. Acrolein increases 5-lipoxygenase expression in murine macrophages through activation of ERK pathway. Toxicol. Appl. Pharmacol. 245: 76-82.
71. Borchers, M.T. et al., 2007. CD8+ T cells contribute to macrophage accumulation and airspace enlargement following repeated irritant exposure. Exp. Mol. Pathol. 83: 301-310.
72. Witschi, A. et al 1992. The systemic availability of oral glutathione. Eur. J. Clin. Pharmacol. 43: 667-669
73. Rahman, I. 2011. Pharmacological antioxidant strategies as therapeutic interventions for COPD. Biochim. Biophys. Acta. Nov 9.
74. Aldini, G. et al 2007. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 27: 817-868.
75. Cai, S. et al 2009. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats. Respirology 14: 354-359.
76. Stav, D. & M. Raz 2009. Effect of N-acetylcysteine on air trapping in COPD: a randomized placebo-controlled study. Chest Aug; 136: 381-386.
77. Black, P.N. et al 2004. Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease. BMC Pulm. Med. 6: 13.
78. Schermer, T. et al 2009. Fluticasone and N-acetylcysteine in primary care patients with COPD or chronic bronchitis. Respir. Med. 103: 542-551.
79. Decramer, M. et al 2005. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 365: 1552-1560.
80. Olsson, B. et al 1988. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur. J. Clin. Pharmacol. 34: 77-82.
81. Aitio, M.L. 2006. N-acetylcysteine - passe-partout or much ado about nothing? Br. J. Clin. Pharmacol. 61: 5-15.
82. Sadowska, A.M., B. Manuel-Y-Keenoy & W.A. De Backer 2007. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm. Pharmacol. Ther. 20: 9-22
83. Burcham, P.C. & S.M. Pyke 2006. Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection. Mol. Pharmacol. 69: 1056-1065.
84. Wondrak, G.T. et al 2002. Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 63: 361-373.
85. Vistoli, G. et al 2009. Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species. Chem. Med. Chem. 4: 967-975.
86. Zhu, Q. et al 2011. Acrolein scavengers: reactivity, mechanism and impact on health. Mol. Nutr. Food Res. 55: 1375-1390.
87. Higgins, L.G. et al 2009. Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. Toxicol. Appl. Pharmacol. 237: 267-280.
88. Kode, A. et al 2008. Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 294: L478-L488.
89. Balstad, T.R. et al 2011. Coffee, broccoli and spices are strong inducers of electrophile response element-dependent transcription in vitro and in vivo-studies in electrophile response element transgenic mice. Mol. Nutr. Food Res. 55: 185-197.
90. Churg, A., D.D. Sin & J.L. Wright 2011. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use? Am. J. Respir. Cell Mol. Biol. 45: 1111-1115.
91. Churg, A. & J.L. Wright 2009. Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 6: 550-552.
92. Churg, A., M. Cosio & J.L. Wright 2008. Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Physiol. Lung Cell Mol. Physiol. 294: L612-L631.